Knights of Columbus Asset Advisors’s Idexx Laboratories IDXX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,433	Closed	-$724K	–	401
2024 Q3	$724K	Sell	1,433 -1,823	-56%	-$886K	0.05%	252
2024 Q2	$1.59M	Buy	3,256 +48	+1%	+$24.1K	0.1%	228
2024 Q1	$1.73M	Buy	3,208 +1,715	+115%	+$937K	0.13%	216
2023 Q4	$829K	Buy	1,493 +5	+0.3%	+$2.35K	0.05%	260
2023 Q3	$651K	Buy	1,488 +55	+4%	+$27.4K	0.06%	259
2023 Q2	$720K	Buy	1,433 +25	+2%	+$12K	0.06%	261
2023 Q1	$704K	Buy	+1,408	New	+$674K	0.07%	251

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Knights of Columbus Asset Advisors's IDXX Position: Q4 2024 in Review

Knights of Columbus Asset Advisors sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 1,433 shares — an estimated $724K sold.

Knights of Columbus Asset Advisors first reported a position in IDXX in Q1 2023 and held it in 7 quarters. The position peaked at $1.73M in Q1 2024. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Knights of Columbus Asset Advisors reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 1,433 Idexx Laboratories shares in Q4 2024, an estimated $724K.
Knights of Columbus Asset Advisors first reported a position in Idexx Laboratories in Q1 2023 and held it in 7 quarters.
Knights of Columbus Asset Advisors's Idexx Laboratories position peaked at $1.73M in Q1 2024.
1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.